Bank of New York Mellon’s Caribou Biosciences CRBU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.7K | Sell |
14,013
-210,373
| -94% | -$265K | ﹤0.01% | 4097 |
|
|
2025
Q1 | $205K | Sell |
224,386
-631
| -0.3% | -$576 | ﹤0.01% | 3861 |
|
|
2024
Q4 | $358K | Sell |
225,017
-15,809
| -7% | -$25.1K | ﹤0.01% | 3667 |
|
|
2024
Q3 | $472K | Sell |
240,826
-67,447
| -22% | -$132K | ﹤0.01% | 3546 |
|
|
2024
Q2 | $506K | Buy |
308,273
+38,098
| +14% | +$62.5K | ﹤0.01% | 3577 |
|
|
2024
Q1 | $1.39M | Sell |
270,175
-25,059
| -8% | -$129K | ﹤0.01% | 2968 |
|
|
2023
Q4 | $1.69M | Buy |
295,234
+30,991
| +12% | +$178K | ﹤0.01% | 2911 |
|
|
2023
Q3 | $1.26M | Buy |
264,243
+60,242
| +30% | +$288K | ﹤0.01% | 3033 |
|
|
2023
Q2 | $867K | Buy |
204,001
+18,007
| +10% | +$76.5K | ﹤0.01% | 3277 |
|
|
2023
Q1 | $988K | Sell |
185,994
-3,350
| -2% | -$17.8K | ﹤0.01% | 3131 |
|
|
2022
Q4 | $1.19M | Buy |
189,344
+7,873
| +4% | +$49.4K | ﹤0.01% | 3105 |
|
|
2022
Q3 | $1.91M | Buy |
181,471
+34,286
| +23% | +$362K | ﹤0.01% | 2883 |
|
|
2022
Q2 | $799K | Buy |
147,185
+5,923
| +4% | +$32.2K | ﹤0.01% | 3319 |
|
|
2022
Q1 | $1.3M | Buy |
141,262
+73,427
| +108% | +$674K | ﹤0.01% | 3149 |
|
|
2021
Q4 | $1.02M | Buy |
67,835
+19,704
| +41% | +$297K | ﹤0.01% | 3376 |
|
|
2021
Q3 | $1.15M | Buy |
+48,131
| New | +$1.15M | ﹤0.01% | 3309 |
|